cs0159
Showing 1 - 2 of 2
Primary Biliary Cholangitis Trial in Shanghai (CS0159, Placebo)
Recruiting
- Primary Biliary Cholangitis
- CS0159
- Placebo
-
Shanghai, ChinaShanghai Xuhui Central Hospital
Dec 29, 2022
Primary Sclerosing Cholangitis (PSC) Trial in Daytona Beach (CS0159)
Completed
- Primary Sclerosing Cholangitis (PSC)
- CS0159
-
Daytona Beach, FloridaLabcorp Clinical Research Unit, Inc.
Oct 15, 2022